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From previous studies on the reactivity of estradiol 2,3-quinone towards deoxyribonucleo-
sides, it was demonstrated that several isomeric adducts were formed. Although adduction on
steroid ring A or B has been evidenced using sequential MSn experiments, in some cases
attachment positions are difficult to identify unambiguously. In this work, 2-hydroxyestradiol
labeled with deuterium at various positions [6 (1); 6-7 (2); 6-6-7 (3)] have been used.
Isomeric adduct differentiation could be achieved using LC-ESI-MSn. The m/z shift of the
quasi-molecular ions as well as the fragmentation pathways suggested that adduction could
occur on both C6 and C9 sites of the steroid B ring: Nucleophilic attack of the base on the C6
position of the steroid led to major adducts and addition of the base on the activated C9 site
gave minor adducts that were found to be unstable. LC-MSn experiments carried out under
deuterated medium provided information about some fragmentation processes by studying
the m/z shift of fragment ions: (1) the loss of deoxyribose from the quasi-molecular ions took
place according to a process involving a deuterium transfer from the deoxyribose alcohol
function; (2) the cleavage of the steroid-base linkage involved a deuterium transfer from the
hydroxy group of the catechol and likely occurred via the formation of an ion-dipole complex.
The model studies conducted in this work provide new information on the fragmentation
mechanisms of covalent adducts formed from estrogen quinones and deoxyguanosine, the
most reactive DNA base. Besides, the first unequivocal characterization of adducts involving
the steroid C9 position is shown by using deuterium labeled estrogen quinones. (J Am Soc
Mass Spectrom 2003, 14, 364–372) © 2003 American Society for Mass Spectrometry
The enzymatic hydroxylation of the aromatic Aring of estrogens via cytochrome P450 enzymesleading to catechol estrogens represents one of
the major metabolic pathways of estrogens [1–3]. Cate-
chol estrogens are mainly inactivated by conversion
into their O-methylated [4] or glucuronide and sulfate
conjugated forms [5]. If those preventive pathways are
not completed, catechol estrogens can undergo further
metabolic activation steps to quinones, highly electro-
philic species that can covalently bind to nucleophilic
groups, via Michael addition reactions [2, 6–8]. In
particular, the adduction of catechol estrogens to DNA
bases [2, 7, 8] is known to induce mutations [9, 10] that
may initiate cancer [1, 2]. The major protective pathway
against this process is the reaction with glutathione [4,
11–13] yielding conjugates which can be easily excreted.
The reactions of estradiol-3,4-quinone with deoxyribo-
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nucleosides have been extensively studied [8, 14–16]
and the major covalent adduct formed from model
reactions was detected in vivo from rats [17] or hamsters
[18] treated with 4-hydroxyestradiol.
The occurrence of DNA adducts can be evidenced
with great sensitivity using immunoassays and 32P
post-labelling [7, 19], but these methods cannot pro-
vide structural information. Because of its sensitivity
and specificity, mass spectrometry appears to be a
powerful tool for exploring this field of investigation
[20 –22]. Moreover, the possibility of on-line coupling
with separation techniques, such as HPLC or CE,
enhances the detection capabilities of this method
[23–25]. Among different soft desorption-ionization
techniques (e.g., MALDI, FAB, TSP), electrospray
ionization is now commonly used for DNA adduct
analysis, because of the very soft desolvation condi-
tions which avoid fragile bond cleavages. Although
negative ESI is widely used for the analysis of un-
modified [26, 27] as well as modified oligonucleotides
[28 –30], the adducts formed between nucleosides and
electrophilic reagents are generally analyzed using
positive ionization [31–33], mainly for better sensitiv-
ity reasons. In previous works [34], the resulting
products from the reactivity of estradiol-2,3-quinone
towards desoxyribonucleosides have been investi-
gated using LC-ESI-MSn. Depending upon the sites of
both the DNA base and the steroid involved in the
Michael addition process, several isomeric com-
pounds were formed, in particular with dG which
was found to be the most reactive deoxyribonucleo-
side [8, 34]. Regio- and stereo-isomeric adducts have
been identified using concomitant LC-ESI/MSn and
NMR methodologies [35]. Although the use of se-
quential LC-MSn experiments allowed to determine
the regiochemistry of adduction (e.g., at the A or B
ring of the steroid), in some cases, the linkage posi-
tion could not be clearly evidenced. In this context,
studies using labeled compounds with deuterium
atoms at various sites have been undertaken in order
to highlight the differentiation of isomeric adducts by
studying the mass shift and the fragmentation pat-
tern of their corresponding quasi-molecular ions,
thus providing additional information on the adduc-
tion site.
In the present work, deuterium labeled 2-hydroxy-
17-estradiol (2OHE2) [i.e., 6 (1); 6-7 (2); 6-6-7
(3)] have been synthesized (Scheme 1). The correspond-
ing labeled quinones have been formed and let to react
with deoxyguanosine. The resulting crude mixtures
were directly analyzed by LC-ESI-MSn using previously
developed analytical conditions [34]. Various LC-MS2
and LC-MS3 experiments into an ion trap have been
performed via resonant excitation of the different se-
lected ions. LC-MSn experiments using deuterated mo-
bile phases have also been carried out in order to clarify
some fragmentation processes.
Experimental
Mass Spectrometry
All experiments were performed on a Finnigan LCQ ion
trap mass spectrometer (Thermo Quest, Les Ulis,
France) equipped with an ESI source operated in the
positive mode using the following conditions: Needle
voltage (5 kV); heated capillary temperature (230 °C);
capillary voltage (4 V); tube lens offset (5 V). Nitrogen
was used as the sheath gas at a flow rate of 80% (arb.
units). All spectra were acquired using AGC (Automat-
ic Gain Control). MSn experiments were carried out
using He as collision gas. Collision energies were ad-
justed in order to get maximum structural information
for each experiment, i.e., typically 17–20% for MS/MS
on the quasi-molecular species, and 21% for MS3 exper-
iments (100% collision energy corresponds to 5 V peak
to peak). In all MSn experiments, ions were isolated at
qz 0.83 with 1.5 u as ion isolation width and excited at
qz 0.25.
Liquid Chromatography
Liquid chromatography has been used to introduce the
samples into the ESI source at a 0.2 ml/min flow rate.
This was carried out using a Thermo Separation P4000
pump (Thermo Quest) fitted with a Rheodyne injector.
The LC column used was an Ultrabase 5 m C18
column (25  2 mm) from SFCC (Eragny, France). The
following gradient elution was used: 100% A to 85% A
from 0 to 5 min., then 85% A to 50% A from 5 to 30 min.,
and 50% A to 100% B from 30 to 40 min., and finally
100% B from 40 to 60 min., with A, H2O/CH3OH/
Scheme 1. Synthesis of deuterium labeled estradiol.
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CH3COOH (90:10:0.2) and B, H2O/CH3OH/CH3COOH
(10:90:0.2).
Materials
The synthetic procedure used for the preparation of the
studied adducts from the different deuterated com-
pounds was described in the literature [8]. Briefly, the
2-hydroxy derivatives of the deuterated compounds
were prepared according to the method described by
Gelbke et al. [36]. The deuterated quinones were pre-
pared by oxidation in acetonitrile at 40 °C of the
corresponding catechols using activated manganese di-
oxide utilizing a procedure published by Abul-Hajj et
al. [37]. The resulting suspension was then filtered
directly into a stirred solution of dG as previously
described [8] and let to react 5 h at room temperature.
Compounds 1, 2, 3 were prepared from the 6-keto-
17-estradiol diacetate 4 (Scheme 1). 4 was prepared
from 17-estradiol as described by Garza and Rao [38]
and reduced with sodium borohydride (deuterated or
not) to give the alcohols 5 or 7. These products were
dehydrated to give the Compounds 6 or 8, which were
then hydrogenated on Pd/C as catalyst either with
hydrogen or with deuterium gas. The stereochemistry
of all the deuterated compounds was checked by com-
parison of the corresponding 1H NMR spectra with that
of 17-estradiol.
Synthesis of compounds 1 and 3. A solution of 4 (100 mg)
in 3.3 mL of methanol-d4-tetrahydrofuran-d8 (10:1, vol/
vol) was stirred at 15 °C with sodium borohydride-d4
for 30 min. Acetic acid (0.15 mL) was added and the
mixture stirred for 85 min. After addition of water (50
mL), extraction with ethylacetate and drying over mag-
nesium sulfate, 6-2H-6-hydroxy-17-estradiol diacetate
(5) was obtained (46% yield).
A methanolic solution of 5 (12 mg in 12 mL) was
stirred for 8 h with 1N HCl (8 mL), then for 15 h more
with 1N HCl (4 mL). After methanol evaporation,
washing with water, extraction with ethylacetate, and
drying over magnesium sulfate, 41mg of deuterated
Compound 6 were obtained (47% yield). A solution of
30 mg of 6 in a mixture of 8 mg 10% Pd/C in
ethylacetate (2 mL) was hydrogenated with D2 at atmo-
spheric pressure to give the Compound 3 after filtration
and evaporation. A similar procedure with H2 led to the
Compound 1.
6-2H-17-estradiol (1): 1H NMR (in CD3OD),  0.77
(s, 3H, CH3), 1.14 (m, 1H, H14), 1.2-1.55 (m, 6 H, H12,
H7, H15, H8, H11, H16), 1.65 (m, 1H, H15), 1.84 (d,
1H, H7), 1.92 (dt, 1H, H12), 2.0 (m, 1H, H16), 2.10 (td,
1H, H9), 2.25 (dq, 1H, H11), 2.75 (d, J¢5.5, 1H, H6), 3.62
(t, 1H, H17), 6.47 (s, 1H, H4), 6.53 (d, 1H, H2), 7.06 (d,
1H, H1).
6,6,7-2H-17-estradiol (3): 1H NMR (in CD3OD), 
0.77 (s, 3H, CH3), 1.14 (m, 1H, H14), 1.2-1.55 (m, 6 H,
H12, H7, H15, H8, H11, H16), 1.65 (m, 1H, H15), 1.84
(s, 1H, H7), 1.92 (dt, 1H, H12), 2.0 (m, 1H, H16), 2.10
(td, 1H, H9), 2.25 (dq, 1H, H11), 3.62 (t, 1H, H17), 6.47
(s, 1H, H4), 6.53 (d, 1H, H2), 7.06 (d, 1H, H1).
Synthesis of compound 2. 100 mg of 4 in methanol (4
mL) and tetrahydrofuran (1 mL) were slowly added to
a solution of sodium borohydride (70 mg in 0.1 mL
water) at 0 °C. This mixture was stirred at 0 °C for 30
min and 1 h more after addition of acetic acid (0.1 mL).
After extraction, washing and drying, the crude prod-
uct was purified on silica plates: 65mg of solid 6-hy-
droxy-17-estradiol diacetate 7 were obtained (65%
yield). A mixture of 38 mg of 7 in methanol (5 mL) and
1N HCl (0.7 mL) was stirred at 80 °C for 3 h. Then water
(20 mL) was added. After extraction, neutralization,
drying, and purification on silica plates, 14 mg of the
unsaturated Compound 8 were obtained (51% yield).
As described above, catalytic hydrogenation with D2 on
8 led to the 6,7-2H-17-estradiol 2 with a 45% yield. The
H2 or D2 addition proceeds on the  face.
6,7-2H-17-estradiol (2): 1H NMR (in CD3OD), 
0.77 (s, 3H, CH3), 1.14 (m, 1H, H14), 1.2-1.55 (m, 6 H,
H12, H7, H15, H8, H11, H16),.1.65 (m, 1H, H15), 1.84
(dd, 1H, H7), 1.92 (dt, 1H, H12), 2.0 (m, 1H, H16), 2.10
(td, 1H, H9), 2.25 (dq, 1H, H11), 2.75 (d, J5.0, 1H, H6),
3.62 (t, 1H, H17), 6.47 (s, 1H, H4), 6.53 (d, 1H, H2), 7.06
(d, 1H, H1).
Results and Discussion
Labeled Covalent Adducts Molecular Weights
LC-ESI-MS analyses of the different crude reaction
mixtures revealed several isomeric adducts eluted at
two different retention times, i.e., 30.4 and 31.6 min, and
reported as a and b isomers in Table 1, together with
their respective molecular weight and the m/z of their
labeled protonated molecular species. As shown in
Table 1, each chromatographic peak consisted of a
mixture of isotopomers as indicated by the isotopic
Table 1. Isomeric adducts obtained from reactions of deuterium labeled steroids 1, 2, 3 with dG.
Adducts M.W.
Isomers
(1)  dG 554 (2)  dG 555 (3)  dG 556
aa bb aa bb aa bb
Quasi-molecular ions m/z 555(Md1H
,75%) 556(Md2H
,75%) 557(Md3H
,20%)
554(Md0H
,25%) 555(Md1H
,25%) 556(Md2H
,80%)
aretention time: 30.4 min.
bretention time: 31.6 min.
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patterns of the quasi-molecular species. It must be
noted that unstable adducts (without deoxyribose moi-
ety) were not observed in our work in contrast with
previously published results [34]. This was very likely
due to the low yield of the reactions conducted in our
study.
First, the direct molecular weight measurement of
the various labeled covalent adducts provided informa-
tion on the attachment position of the nucleoside and
steroid partners (Table 1). As previously emphasized [8,
34], almost all adducts were formed by a nucleophilic
attack of the deoxyguanosine at the C6 position of the
steroid substrate. This suggested that o-quinones
isomerized into more electrophilic p-quinone methide
forms, which underwent Michael addition reactions
with deoxyguanosine, thus resulting in benzylic ad-
ducts (Scheme 2). In a similar way, the formation of
adducts between quinones and glutathione was also
shown to involve such isomerization processes [39–42].
Thus, by analogy with a previously reported base-
catalyzed isomerization process [41], a mechanism in-
volving acidic catalysis can be proposed for the forma-
tion of covalent adducts between estradiol-2,3-quinone
and deoxyguanosine in the acidic medium used in this
work (Scheme 2).
The reaction of deuterium labeled steroids led to
covalent adducts displaying shifted m/z of the quasi-
molecular species. As indicated in Table 1, major ad-
ducts were detected at m/z 556 from both 2 and 3
isotopomers and at m/z 555 from 1. This indicated one
deuterium atom (C6/ or C7 position) was lost from
3 whereas the deuterium atoms from 1 and 2 were
preserved. This behavior suggested that the formation
of these adducts may involve the elimination of one H
or D atom from the C6 position of the steroid B ring.
Indeed, the m/z of the observed quasi-molecular ions
depended upon the nature of the atom lost during the
oxidation step of the catechol estrogen into its corre-
sponding quinone methide form as described in
Scheme 2. The loss of H at position C6 from 1 and 2, led
to the major isotopomeric covalent adduct ions at m/z
555 and 556, respectively. Conversely, the elimination
of one D at position C6 for 1 and C6 for 2 observed as
a minor process led to the occurrence of ions at m/z 554
and 555. This result indicated that an isotope effect may
occur in the formation of the p-quinone methides for 1
and 2, in which the hydrogen elimination is favored
compared to that of the deuterium atom. A similar
isotope effect has also been reported for the isomeriza-
tion of 4-propyl-o-quinone into its tautomeric p-
quinone methide form [41] and was in the range of
kH/kD  5.5  0.6 at 37 °C.
On the other hand, the presence of some adducts
detected as the Md3H
 ions at m/z 557 (and [Md3Na]

ions at m/z 579) from 3 indicated that the initial labeling
could also be preserved on the trideuterated compound
(Figure 1). Hence, in this case, a base addition occurring
at a site other than the C6 position (i.e., at the C9
position or the A ring) had to be considered.
MSn Experiments on the m/z 555 and 556 Ions
from 1, 2, and 3
As indicated on Figure 2 a, b, and c, all the ionic adduct
species (a isomers as well as b isomers) at m/z 555 and
556 ion decomposed according to the same fragmenta-
tion pathway. This fragmentation mainly involved the
loss of the deoxyribose moiety from the quasi-molecu-
lar ions in the MS2 step, whereas the resulting fragment
ion underwent the cleavage of the steroid-base bond
leading to the formation of the protonated base (m/z
152) and [MH-dG] (m/z 288 or 289) as a pair of
complementary ions. However, slight differences can be
observed on the CID spectrum of 1 (Figure 2a) when
compared to the CID spectra of 2 and 3 (Figure 2b and
c), concerning in particular the stability of the molecular
species. Indeed, when submitted to the same isolation
and excitation conditions in the ion trap cell, the 1H
species seems to be more stable than its 2H and 3H
counterparts. This difference may be due to isotope
effects, which seem difficult to interpret. However, the
subsequent MS3 spectra acquired from the m/z 440 (or
439) daughter ions are completely identical for 1 (Figure
2a), 2 (Figure 2b), and 3 (Figure 2c). This shows that
these m/z 440 (or 439) selected product ions are the same
ionic species. These results were consistent with the
attachment of the base at the steroid B ring and indi-
cated that all the adduct ions (a and b isotopomers),
possessed similar structures. As already reported [8],
nucleophilic attack at the prochiral C6 atom of the
steroid resulted in the formation of two diastereoiso-
mers (a and b isomers) which corresponded to the 
and  forms as illustrated in Scheme 3 on the basis of
Compound 3. The formation of the quinone methide
Scheme 2. Proposed mechanism for the isomerization of the
o-quinone to the p-quinone methide.
Figure 1. Positive ESI mass spectrum of the b isomer of (3 
dG).
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intermediate implies a loss of stereochemistry at the C6
position of the steroid as reported in Scheme 2, accom-
panied by an isotope effect concerning the H or D
elimination. This explains the occurrence of isoto-
pomers at M and M  1 on both diastereoisomers
formed according to Michael addition processes. Such
isomeric adduct species have already been evidenced
by LC-ESI-MS/MS and NMR and it has been shown
that both diastereoisomers could be separated by HPLC
[34, 35].
MSn Experiments on the m/z 557 Ions from 3:
Evidence for a Reaction at the Steroid C9 Position
The m/z 557 ions from the labeled Compound 3 pos-
sessed a significant relative abundance (65% of the peak
m/z 556, see Figure 1). In this case, the contribution of
the 13C natural isotopic abundance of the m/z 556 ions,
and the occurrence of covalent adducts which pre-
served the three initial D atoms should be considered.
Taking into account that the natural isotopic contribu-
tions at M  1 for a C28H35O7N5 species, the relative
abundance of the peak at m/z 557 should correspond to
ca. 33% of the protonated ions at m/z 556. The actual
relative abundance observed for the m/z 557 ion is 65%.
The same trend is observed for the MNa species, with
the m/z 579 ion relative abundance corresponding to
65% of the peak at m/z 578 (Figure 1). This indicated that
the m/z 557 ion also contained a molecular species in
which the three initial D atoms were preserved, sug-
gesting that the adduction process may also occur on a
site other than the C6 position. Moreover, the CID
spectrum presented in Figure 2d also showed that the
behavior of the m/z 557 ions from 3 towards collisional
Figure 2. MS2 and MS3 spectra of ESI-produced protonated molecular ions from the b isomer of (a)
(1  dG), (b) (2  dG), and (c and d) (3  dG).
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activation was specific. In this case, the main fragmen-
tation pathways consisted of a water elimination and
steroid-base linkage cleavage to yield the m/z 539 and
290 ions, respectively, whereas the loss of deoxyribose
was observed as a weak process. This particular pattern
has never been observed on estrogen quinone-deoxyri-
bonucleoside covalent adducts until this work, indicat-
ing that this adduct should have a different structure.
From previously published results [8], the adduction
process at the steroid A ring could be ruled out since the
nucleobase and steroid are strongly bonded in such
covalent adducts, which mainly dissociate according to
charge-remote fragmentations [8, 34, 35]. Moreover, in
this case, the presence of both complementary ions at
m/z 152 and 290 in the MS3 spectrum of the [MH-
deoxyribose] m/z 441 ions (resulting from the decom-
position of the parent m/z 557 ions) was characteristic of
the cleavage of the steroid-base linkage, consistent with
a linkage at the steroid B ring. The presence of a weak
signal at m/z 153 was very likely due to the 13C
contribution of the m/z 556 ions also selected at m/z 557
and could be attributed to the 13C contribution of the
protonated base. Thus, it can be concluded that the m/z
557 ions probably correspond to a covalent adduct
resulting from the addition of the base on the activated
C9 site as reported in Scheme 3. As the C9 site was also
a prochiral center, two diastereoisomers could also be
expected. However, these C9 attachment adducts de-
tected at m/z 557 appeared to be eluted at retention
times similar to those of the a and b isomers of the C6
attachment adducts, respectively. The greater abun-
dance of the m/z 290 ions relative to the m/z 441 ions in
the MS2 spectrum of the m/z 557 ions (Figure 2d) could
be expected from a C9 adduct since the elimination of
the base moiety can be favored because of steric decom-
pression effects and the tertiary character of the pro-
duced carbonium site.
The formation of some adduct ions at m/z 555 (d1)
and 556 (d2) could also be expected from 1 and 2,
respectively, considering the same nucleophilic attack
at the C9 position of the steroid resulting in the preser-
vation of the initial number of deuterium atoms, but the
occurrence of these species could not be evidenced in
our experiments.
It can be concluded from these results that the
reaction of dG at the C9 position led to unstable
adducts, which could be evidenced by the specific
fragmentation pathway observed from the m/z 557 ion
of 3 from freshly prepared reaction mixtures, and which
decomposed after several hours. This assumption was
further supported by the change in the isotopic profile
initially observed (Figure 1) from a m/z 557 relative
intensity of 65% to a relative intensity below ca. 30%
when the same sample was analyzed some days after.
Furthermore, the CID spectrum of the m/z 557 ions
selected from 3 became similar to those of the other
quasi-molecular ions described in Figure 2a to c, i.e., it
displayed a major fragment ion at m/z 441 whereas no
diagnostic fragment ions at m/z 290 and 539 were
observed (data not shown). This behavior indicated that
after several hours, the C9 attachment adducts were
degraded and the detected m/z 557 ions only corre-
sponded to the 13C isotopic contribution of the m/z 556
ions formed according to the C6 addition process.
Although adducts with the C9 attachment had never
been clearly evidenced in previous works, a compound
identified as the 11-oxo-2OHE2 was detected in crude
reaction mixtures, and its origin was attributed to the
degradation of such C9 covalent adducts [35, 43]. Alter-
natively, the nucleophilic attack at the C9 position was
also proposed for the formation of some estrogen qui-
none-glutathione adducts, but the occurrence of such
species could not be evidenced [39, 42]. In this case, the
unstable character of such adducts was also reported
and only products formed by elimination of glutathione
(i.e., 9-dehydro-4OHE and 9-dehydro-2OHE from
4OHE-o-quinone and 2OHE-o-quinone, respectively)
were identified as the end products of the degradation
of such transient adduct species [39, 42].
Scheme 3. Proposed reaction pathway for adduct formations in the reaction between 3 and dG.
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Fragmentation Processes Under MSn Conditions
as Revealed by LC-MSn Analyses in Deuterated
Medium
In order to gain complementary information on the
covalent adduct fragmentation processes, LC-MSn anal-
yses have been performed using deuterated mobile
phases. The m/z of the various ionic species of interest
are reported in Table 2. Under these conditions, H/D
exchanges occurred in solution and the m/z of quasi-
molecular ions were shifted by 8 Th, which is consistent
with the occurrence of seven exchangeable hydrogen
atoms in the covalent adduct structure and the associ-
ated addition of a deuterium for ionization. MS/MS as
well as MS3 experiments were carried out on these
various species (Table 2). The resulting low energy CID
spectra of these species mainly displayed product ions
at m/z 445 from (2OHE2  dG) and m/z 447 ions from
(2  dG) or (3  dG), corresponding to the loss of the
deoxyribose moiety from the molecular species. Sur-
prisingly, a specific loss of 117 u instead of the expected
118 u loss has been observed for the deoxyribose moiety
elimination process. Taking into account the exchange-
able hydrogen atoms on the deoxyribose moiety, the
formation of these fragment ions by loss of 117 u was
unexpected, since the H/D exchanges in the ion trap
were minor during the MS/MS experiment period as
observed from the fragmentation of protonated stan-
dard compounds in deuterated medium (data not
shown). Hence, a process involving a deuterium migra-
tion from the deoxyribose to the base moiety could
explain the m/z shift of fragment ions formed by the loss
of deshydrogenated deoxyribose from the quasi-molec-
ular ions (Scheme 4), although other processes (e.g.,
formation of an ion–dipole complex followed by H/D
exchange) could also rationalize the formation of such
species.
From the MS3 experiments carried out on the m/z 445
or 447 ions, the m/z shift observed for the product
protonated base (m/z 152 to 157) showed that an elim-
ination mechanism involving a hydrogen on C7 posi-
tion could be ruled out for the formation of such
species. A mechanism involving a D transfer should
preferably be considered. Hence, the cleavage of the
steroid-base linkage could rather be explained via the
formation of an ion–dipole complex accompanied by a
deuterium transfer from the OD group of the catechol to
the neutral base moiety of such a complex as presented
in Scheme 4.
Conclusion
In this study, the use of deuterated 2-hydroxyestradiol
allowed the differentiation of isomeric adducts using
LC-ESI-MSn. The study of the m/z shift as well as the
fragmentation pathways observed for the quasi-molec-
ular ions have shown that addition of the base could
occur on both the C6 and C9 sites of the steroid B ring
in its quinone-methide form. Although compounds
attributed to the degradation of an adduct formed by
nucleophilic attack of the base on C9 position have
already been identified [39, 42, 43], the corresponding
adducts had never been clearly evidenced by LC-MSn
until this work. Some complementary work needs now
to be developed in order (1) to achieve a complete
chromatographic separation of the C6 and C9 adducts
which coelute in our LC-MS experiments and (2) to
improve the understanding of the particular fragmen-
tation process of this adduct.
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Table 2. m/z ratios of the various ionic species obtained by LC-
ESI/MSn analyses of crude reaction mixtures in deuterated
medium.
Adducts
MdD

(m/z)
[MdD-deoxyribose]

(m/z)
BD2

(m/z)
2OHE2  dG 562 ➪
MS2 445 ➪
MS2 157
(2)  dG 564 ➪
MS2 447 ➪
MS2 157
(3)  dG 564 ➪
MS2 447 ➪
MS2 157
Scheme 4. Proposed mechanism for the fragmentation of the [Md7  D]
 ion of 2-OHE2-6-N
2-dG
under MSn conditions.
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